ADCs have huge potential in treating challenging diseases. It is essential that all necessary steps are in place to ensure their safe handling.
List view / Grid view
Lonza Pharma & Biotech
14 March 2022 | By
At Lonza Small Molecules, our connected experts work together to provide contract development and manufacturing services, helping pharma and small biotech companies deliver their medicines to patients in need. From the earliest stages of discovery to the final drug product, we can simplify your outsourcing experience with our reliable, timely…
Liquid-filled hard capsules: A flexible tool for rapid access to the clinic with poorly soluble and/or highly potent compounds
21 October 2020 | By Lonza Pharma & Biotech
Watch our on-demand webinar to learn about liquid-filled hard capsule technology has a proven record for addressing complex active pharmaceutical ingredient (API) formulation challenges, including bioavailability enhancement.